Empowering patient perspectives in drug development
With ProPATIENT Solutions™, our Patient Engagement Strand, we follow a patient-centered design and our own guidelines to create a full cycle of perfectly flowing drug development. At Accelsiors, we believe that patient perspectives are essential for developing effective and meaningful therapies. ProPATIENT Solutions™ is our Patient Engagement Strand designed to include the patient voice at every stage of your clinical trial, from initial feasibility to final study closure.
We utilize the principles of Patient-Focused Drug Development (PFDD) to gain a deeper understanding of the patient’s experience. By actively engaging patients and caregivers throughout the research process, we ensure that your trial is designed and executed with their needs and priorities in mind.
Our Approach
- Feasibility and Clinical Trial Site Selection: Assessing patient access and recruitment potential, selecting sites with the ideal patient population and ensuring optimal enrollment.
- Patient Recruitment Strategies: Developing tailored recruitment plans that address the unique challenges of your study and effectively target the right patients.
- Patient Engagement: Facilitating meaningful interactions between patients, caregivers, and your study team, fostering trust and collaboration.
- Data Collection and Analysis: Utilizing innovative methods to capture and analyze patient-reported outcomes, incorporating their voices into your research data.
The Accelsiors Difference
- Proactive Planning: Integrating patient-centric considerations into the study design from the outset, ensuring a truly patient-focused approach.
- Data-Driven Insights: Utilizing real-world data and recruitment simulations to optimize patient enrollment and retention strategies.
- Collaborative Partnerships: Building strong relationships with patient advocacy groups and communities to ensure their voices are heard and their needs are met.
